Luisa Albano
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
Journal: Nature medicine
Published: July 08, 2024
Pneumocystis murina lesions in lungs of experimentally infected Cd40l-/- mice.
Journal: Veterinary pathology
Published: May 17, 2024
Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cells.
Journal: Nature biotechnology
Published: January 25, 2024
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo.
Journal: Molecular therapy. Methods & clinical development
Published: May 25, 2023
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells.
Journal: Blood
Published: December 05, 2022
Genotoxic effects of base and prime editing in human hematopoietic stem cells.
Journal: Nature biotechnology
Published: November 21, 2022
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.
Journal: Cell
Published: December 16, 2021
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome.
Journal: EMBO molecular medicine
Published: October 06, 2020
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking.
Journal: Nature biotechnology
Published: December 06, 2019
Last Updated: 09/26/2026